Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1
- 10 February 2012
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 157 (3), 485-492
- https://doi.org/10.1016/j.jconrel.2011.09.067
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriersJournal of Controlled Release, 2011
- Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry diseaseJournal of Controlled Release, 2011
- Computational model for nanocarrier binding to endothelium validated using in vivo, in vitro, and atomic force microscopy experimentsProceedings of the National Academy of Sciences of the United States of America, 2010
- Shear‐regulated uptake of nanoparticles by endothelial cells and development of endothelial‐targeting nanoparticlesJournal of Biomedical Materials Research Part A, 2009
- Oxygen Microscopy by Two‐Photon‐Excited PhosphorescenceChemphyschem, 2008
- Control of Endothelial Targeting and Intracellular Delivery of Therapeutic Enzymes by Modulating the Size and Shape of ICAM-1-targeted CarriersMolecular Therapy, 2008
- RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1Blood, 2008
- PLGA Nanoparticle−Peptide Conjugate Effectively Targets Intercellular Cell-Adhesion Molecule-1Bioconjugate Chemistry, 2007
- Control of intracellular trafficking of ICAM-1-targeted nanocarriers by endothelial Na+/H+exchanger proteinsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Adhesion molecules: a new target for immunoliposome‐mediated drug deliveryFEBS Letters, 1995